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Knowledge translation (KT) promotes evidenced-based
medicine but methods used to support related practices
are often not evidence based [1,2]. Implementation
research is complex, as it requires taking into account
multiple levels (from patients, multidisciplinary health-
care teams and health facilities to local and national
health care systems), which adds to the significant con-
ceptual and methodological challenges that currently
exist. These challenges are likely the reasons why the
impact of implementation strategies has been modest
and why conclusions that can be drawn from these
approaches and how they should be applied to given
settings are so limited.
There is pressure to improve quality of care, but there
is a lack of information about which interventions work
and under what circumstances. Most studies registered
in the Cochrane collaboration are RCTs (~350,000), but
only 2,400 are experimental and quasi-experimental
trials of interventions to improve health care delivery.
There is a need to shift the focus from developing new
treatments to developing approaches that deliver what is
already known to work and to create and evaluate inter-
ventions from evidence-based knowledge. Given the lim-
ited evidence base to work from, people involved in
quality improvement (QI) have a responsibility to evalu-
ate the effectiveness of their efforts not only because
many interventions are ineffective and may lead to a
waste of resources, but also because evaluation creates
knowledge that may benefit others.
When considering how to evaluate the impact of an
intervention, one should first consider whether the interest
is in local knowledge (i.e., whether an intervention worked
in the context in which it was implemented, which is of
interest to managers responsible for QI within an institu-
tion) or generalizable knowledge (i.e., whether an interven-
tion is likely to work in comparable settings which is of
interest to KT researchers). Determining the need for local
or generalizable knowledge and available resources drives
most choices in KT intervention study designs. Evaluation
study designs include randomized controlled trials (the
gold standard for assessing causality and impact of inter-
ventions); and non-randomized or quasi-experimental
designs (e.g., controlled/uncontrolled before-after, and
interrupted time series designs), which are more subject to
biases but require fewer resources. These designs vary in
their ability to control for bias to increase internal validity,
but even the perfectly valid study may not determine the
degree to which the results can be generalized to real prac-
tice conditions. Pragmatic study designs can facilitate this
by maximizing the relevance of the results for real world
decision-making, often for a broad range of settings.
Despite a large number of studies, many knowledge gaps
still remain. Rigorous evaluation of QI initiatives (using
both quantitative studies to better understand “if” some-
thing works supplemented by qualitative studies to under-
stand “why”) are needed to increase our knowledge of KT
and to improve quality of care.
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